If your BMI is 27 or higher, you may still be an ideal candidate if you manage at least one weight-related medical condition, such as high blood pressure, high cholesterol, or obstructive sleep apnea
Potential Future Users: Reasons for considering usage, weight loss/health goals, likelihood of use, and what factors will be most influential in determining usage
Decades of clinical use confirm it is one of the safest peptides available
Exploring the therapeutic potential of GLP-1 receptor agonists in the management of obstructive sleep apnea: a comprehensive review
2022 NEJM) showed 20.9% weight loss with tirzepatide at 72 weeks
The test measures blood sugar levels, thyroid and kidney function among other components